As part of the NanoAssemblr® Platform, the NanoAssemblr® Ignite™ enables the rapid and controlled manufacture of nanomedicines. Conceived for the development of transformative medicines at the bench scale, the Ignite system has been:
Designed with the End in Mind
Develop a robust, scalable process from the earliest stage A drug product is produced by adhering to the unit process steps necessary for clinical manufacturing. Ignite simplifies the transition into clinical programs by incorporating these fundamental process steps for scale up in the earliest stages of pre-clinical by modelling clinical manufacturing processes at small volumes, costs are reduced, scale up is derisked, and timelines are accelerated.
Designed for the Future
Let technology keep pace with your ideas The next generation of gene therapies, vaccines, and targeted medicines are now achievable with the automated, multi-step synthesis made possible with Ignite. NxGen microfluidic technology, together with Ignite’s three-pump format, provide the basis for expansion to enable new, more sophisticated manufacturing capabilities.
Designed to Maximize Time
Manufacturing processes should not be long or complex. Ignite lowers the barrier to developing transformative medicines by providing a simple, precise, and fast platform, allowing you to focus on what matters—bringing solutions to patients.
Download our brochure here.